IRIS
BARBIERI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.617
AS - Asia 1.520
NA - Nord America 833
SA - Sud America 155
AF - Africa 26
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.159
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.353
US - Stati Uniti d'America 789
SG - Singapore 685
CN - Cina 369
VN - Vietnam 267
FR - Francia 111
BR - Brasile 91
HK - Hong Kong 66
FI - Finlandia 33
DE - Germania 31
AR - Argentina 26
MX - Messico 23
GB - Regno Unito 19
IQ - Iraq 19
BD - Bangladesh 18
CA - Canada 16
IN - India 16
JP - Giappone 14
CH - Svizzera 11
CO - Colombia 11
ID - Indonesia 11
NL - Olanda 9
EC - Ecuador 8
PK - Pakistan 8
KE - Kenya 7
PL - Polonia 7
RU - Federazione Russa 7
CL - Cile 6
ES - Italia 6
PH - Filippine 6
VE - Venezuela 6
AU - Australia 5
IE - Irlanda 5
TH - Thailandia 5
UA - Ucraina 5
AZ - Azerbaigian 4
TR - Turchia 4
ZA - Sudafrica 4
AT - Austria 3
BH - Bahrain 3
DK - Danimarca 3
JO - Giordania 3
MA - Marocco 3
MY - Malesia 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
TN - Tunisia 2
TZ - Tanzania 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EG - Egitto 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
SE - Svezia 1
SN - Senegal 1
SO - Somalia 1
SY - Repubblica araba siriana 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.159
Salva come PNG Salva come JPEG
Città #
Genova 8.444
Genoa 4.570
Vado Ligure 1.220
Rapallo 997
Singapore 333
San Jose 273
Ashburn 144
Lauterbourg 101
Ho Chi Minh City 71
Council Bluffs 69
Beijing 65
Hanoi 64
Hong Kong 64
Bordighera 33
Santa Clara 29
Helsinki 28
Haiphong 26
Frankfurt am Main 23
New York 20
Mexico City 17
Milan 15
Chicago 14
Tokyo 13
Da Nang 11
São Paulo 11
Zurich 10
Los Angeles 9
Tianjin 9
Amsterdam 8
Atlanta 8
Baghdad 8
Biên Hòa 7
Hải Dương 7
Warsaw 7
Nairobi 6
City of London 5
Houston 5
Lappeenranta 5
London 5
Madrid 5
Nha Trang 5
Rome 5
Shanghai 5
Turin 5
Baku 4
Belo Horizonte 4
Buenos Aires 4
Denver 4
Dublin 4
Jakarta 4
Montreal 4
Nuremberg 4
Orem 4
Amman 3
Bangkok 3
Can Tho 3
Cardiff 3
Charlotte 3
Curitiba 3
Des Moines 3
Erbil 3
Guangzhou 3
Lomas de Zamora 3
Marseille 3
Paris 3
Queens 3
Quezon City 3
Quito 3
Santiago 3
Sydney 3
Tashkent 3
Thái Bình 3
Toronto 3
Waterbury 3
Ân Thi 3
Điện Bàn 3
Abu Dhabi 2
Ankara 2
Asunción 2
Belgrade 2
Bismarck 2
Bogotá 2
Brasília 2
Changsha 2
Chennai 2
City of Westminster 2
Copenhagen 2
Córdoba 2
Da Lat 2
Dar es Salaam 2
Fort Lauderdale 2
Guayaquil 2
Kuala Selangor 2
Kyiv 2
Laranjal Paulista 2
Lucca 2
Lấp Vò 2
Manama 2
Medellín 2
Montevideo 2
Totale 16.932
Salva come PNG Salva come JPEG
Nome #
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects 258
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 251
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 242
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells 236
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 233
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? 232
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors 230
Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors 221
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 220
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity 218
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 209
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 209
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors 200
Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma 199
Chemokines and chemokine receptors: New actors in neuroendocrine regulations 197
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity 195
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 193
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 191
Endometrial stem cells and human reproductive failure 190
SDF1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase, Pyk2. 190
1,4-bis(1-naphtyl)-2,3-dinitro-1,3 butadiene a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance. 190
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 188
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 187
Glioblastoma cancer stem cells: response to epidermal growth factor receptor kinase inhibitors 184
Antisense oligonucleotides as therapeutic agents. 184
Drug-repositioning opportunities for cancer therapy: Novel molecular targets for known compounds 184
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma 183
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 183
Differential efficacy of SSTR1, 2 and 5 agonists in the inhibition of C6 glioma growth in nude mice 181
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 180
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 179
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 179
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 177
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 175
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 175
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 173
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 171
Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of Phidianidine A as a new CXCR4 ligand exhibiting antagonist activity 170
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 170
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 168
Differential role of EGF and bFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensitivity 166
17{beta}-ESTRADIOL PROMOTES BREAST CANCER CELL PROLIFERATION INDUCING SDF-1-MEDIATED EGFR TRANSACTIVATION: REVERSAL BY GEFITINIB PRE-TREATMENT. 164
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 160
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 160
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 159
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 159
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 159
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity 158
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 158
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis 158
CXC receptors and chemokines expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation 157
Mutual influence of ROS, pH and CLIC1 membrane protein in the regulation of G1/S phase progression in human glioblastoma stem cells 157
Expression of cyclin D1 correlates with malignancy in human ovarian tumours 154
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential 152
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment 152
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer. 150
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects 149
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study 148
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures 147
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 146
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells 146
A liposomal formulation for inflammation targeting 146
Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells 145
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits 143
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies 142
Biomimetic vesicles for glioblastoma treatment 139
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies 139
Antiproliferative effect of DNA polymerase antisense oligodeoxynucleotides on breast cancer cells. 138
Amyloid-beta Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau 137
Ruta graveolens water extract inhibits cell-cell network formation in human umbilical endothelial cells via MEK-ERK1/2 pathway 137
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 137
The use of antisense oligodeoxynucleotides (aODNs) in immunopharmacology. 136
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 136
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity 135
Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines. 134
Novel Sigma Binding Site Ligands as Inhibitors of Cell Proliferation in Breast Cancer 134
The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells 134
Antitumor activity of a new o rally active organotin compound: a preliminare study in murine tumor models 134
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells 133
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation 132
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells 129
Somatostatin and somatostatin receptors 1, 2 and 5 selective agonists inhibit C6 glioma cell growth in vitro and in vivo: Analysis of activated intracellular pathways 128
Control of gene expression by triplex forming oligonucleotides in human live cells. 128
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 127
Goat anti-human GM-CSF recognizes canine GM-CSF 127
Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas. 126
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract 125
Chemosensitivity of glioblastoma cells during treatment with the organo-tin compound triethyltin (IV) lupinylsulfide hydrochloride. 121
Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases 120
Thymidine Labelling Index as prognostic factor in resected non-small cell lung cancer. 120
Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment 118
Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in Ovarian tumors 116
Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferaton and migration. 114
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound 113
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target 113
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 109
Expression of somatostatin receptors mRNA in human meningiomas and their implication in in vitro antiproliferative activity 109
Somatostatin receptors 1, 2 and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro, via a PTPh-dependent inhibition of ERK1/2. 108
Expression of calpastatin hcast 3-25 and activity of the calpain/calpastatin system in human glioblastoma stem cells: possible involvement of hcast 3-25 in cell differentiation 101
CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumor meningothelial cells in vitro 99
Totale 16.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.660
article - articoli 51.433
book - libri 0
conference - conferenze 2.772
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 455
Totale 109.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021285 0 0 0 0 0 0 0 0 0 137 89 59
2021/20221.381 55 124 73 165 35 102 95 310 66 111 58 187
2022/20231.210 108 82 14 128 147 223 1 106 209 16 149 27
2023/2024897 49 85 21 103 55 192 76 50 41 29 70 126
2024/20253.088 111 180 100 243 391 346 278 614 117 128 261 319
2025/20264.583 626 137 581 446 618 370 654 250 474 427 0 0
Totale 18.507